
Press Releases
Boehringer Ingelheim licenses ProBioGen's novel GlymaxX Technology
ProBioGen Presents GlymaxX - The Novel Glyco-Engineering Technology
Minapharm Pharmaceuticals acquires majority stake in ProBioGen – Dr. Wieland Wolf appointed new CEO
AFFiRiS will explore ProBioGen’s Human Artificial Lymph Node Technology for Vaccine Testing
ProBioGen signs therapeutic protein process development contract with Virdante Pharmaceuticals
ProBioGen Is Granted Divisional Patent on Its Proprietary AGE1 Cell Line
ProBioGen Announces the Appointment of Dr. Volker Sandig to Chief Scientific Officer